Updated:
Chongqing Lummy Pharmaceutical
Chongqing Lummy Pharmaceutical began operations in 1999 under founder Rong Zhao Qiu. The company produces healthcare products and maintains research activities...
Chongqing Lummy Pharmaceutical
Chongqing Lummy Pharmaceutical began operations in 1999 under founder Rong Zhao Qiu. The company produces healthcare products and maintains research activities in its home city. The firm runs production bases in Chongqing Tea Garden New Area, Changshou District, Liuyang in Hunan Province and Chengdu High-tech Zone in Sichuan Province. It collaborates with Sichuan University through the Lummy-Sichuan University Joint Laboratory. A major shareholder is Guangxi Wuzhou Zhongheng Group Co., Ltd. Headquarters sit at the 15th and 16th floors of Building B, Chongqing Academy of Science and Technology. The company holds a pharmaceutical patent portfolio and additional industrial sites. Rong Zhao Qiu serves as CEO while Li Xiaojun acts as person in charge. No recent operational events from the last 24 months appear in available records.
General information
Firm type
Corporate Investor
Year founded
1999
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Chongqing
Corporate office
Chongqing, China
Principals
Rong Zhao Qiu
CEO
Li Xiaojun
Person in charge
Sector focus
Frequently asked questions
Who founded Chongqing Lummy Pharmaceutical?
Rong Zhao Qiu founded the company in 1999 and serves as CEO.
Where does Chongqing Lummy Pharmaceutical maintain production facilities?
Facilities operate in Chongqing, Liuyang in Hunan Province, and Chengdu High-tech Zone in Sichuan Province.
Which academic institution partners with Chongqing Lummy Pharmaceutical?
Sichuan University collaborates through the Lummy-Sichuan University Joint Laboratory.
Who is the largest disclosed shareholder in Chongqing Lummy Pharmaceutical?
Guangxi Wuzhou Zhongheng Group Co., Ltd. holds 23.43 percent.
When did Chongqing Lummy Pharmaceutical list on a stock exchange?
The company listed on the Shenzhen Stock Exchange in 2009.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: